October 2021 Issue

GO TO FULL ISSUE

Get the fastest, most trustworthy advice on how drug therapy changes fit into your everyday practice. Subscribe. Prescriber's Letter

Med Updates

Kloxxado
naloxone
New higher strength (8 mg) nasal spray for emergency treatment of opioid overdose

Kerendia
finerenone
A non-steroidal mineralocorticoid receptor antagonist for patients with chronic kidney disease associated with type 2 diabetes

Azstarys
serdexmethylphenidate/
dexmethylphenidate
A stimulant for ADHD

MORE NEW DRUGS